Michelle Dang
About Michelle Dang
Michael McKenna is a distinguished otolaryngologist and Chief Surgical Officer, known for his pioneering research in otosclerosis and contributions to inner ear drug delivery systems.
Title: Chief Surgical Officer & Co-Founder
Michael McKenna serves as the Chief Surgical Officer and Co-Founder of his organization. He brings a wealth of experience in the field of otolaryngology and has held prominent roles in multiple respected institutions. His leadership in surgical innovation and clinical practice is highly reputed in the medical community.
Education and Expertise: M.D. from University of Southern California School of Medicine
Michael McKenna earned his M.D. from the University of Southern California School of Medicine. He further honed his medical expertise through a residency in otolaryngology at Harvard Medical School, followed by a specialized fellowship in neurotology and skull base surgery at the House Ear Clinic. His extensive education underpins his authoritative knowledge and practice in ear-related medical fields.
Previous Roles: Director and Professor at Harvard Medical School
Prior to his current role, Michael McKenna held the Joseph B. Nadol, Jr. Chair and served as the director of the Division of Otology and Neurotology at Massachusetts Eye and Ear. He was also a professor of otolaryngology at Harvard Medical School. During his tenure, he led significant advancements in the field and contributed to the education of future medical professionals.
Research Contributions: Inner Ear Drug Delivery Systems
Michael McKenna led critical efforts to establish inner ear drug delivery systems over a span of 15 years. His laboratory's research was groundbreaking, particularly in demonstrating the association between the COL1A1 gene and clinical otosclerosis. With over three decades dedicated to studying the molecular pathophysiology of otosclerosis, his contributions have significantly advanced understanding and treatment of this condition.